MedPath

Clinical Effectiveness of(VistaProof)in Comparison With ICDAS-II & Histological Validation for Detecting Occlusal Caries

Completed
Conditions
Light Fluorescence Device
Interventions
Device: vistacam proof
Other: ICDASII
Procedure: fissurotomy
Registration Number
NCT03940170
Lead Sponsor
Mohamed samy El-sayed
Brief Summary

a diagnostic accuracy study control trial is to be held to evaluate the Clinical performance of quantitative light fluorescence based device (Vistacam Proof) in comparison with the visual examination and histological validation in detection of initial pits and fissures caries

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Patients aged from 15 to 50 years.
  • Patient at least has one posterior pits and fissure occlusal caries.
  • No gender restriction
  • Co-operative patients who signed the informed consent.
  • Good general health
  • Acceptable oral health
Exclusion Criteria
  • Pregnancy.
  • Disabilities.
  • Systemic disease or severe medical complications.
  • Allergic history concerning methacrylate.
  • Rampant caries.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
vistacamvistacam proof-
FissurotomyICDASII-
ICDAS IIICDASII-
Fissurotomyfissurotomy-
Fissurotomyvistacam proof-
Primary Outcome Measures
NameTimeMethod
pits and fissure cariesthrough study completion, an average of 1 year

occlusal pits and fissure caries in posterior teeth non-cavitated

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The British University in Egypt

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath